Pricing
Sign up

Nanosphere

Go to market map
Similar Companies
+3 more
Sign in for full access
Short description
Nanosphere develops a molecular diagnostics platform for genomic and protein testing and analysis.
Description
Nanosphere, Inc. is a nanotechnology-based healthcare company, making clinical diagnostic tests that are two to three times as sensitive as those commonly used in hospital labs today and much simpler, taking just hours rather than days or weeks to complete. The company's instruments, which use microfluidics to pull DNA and proteins from a sample, detect genetic variations in blood that make some drugs more effective in some patients than others. The key is an array of gold nanoparticles studded with chemicals that capture characteristic proteins and nucleic acids from clinical samples such as blood.
Last funding
No Way
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Northbrook, Illinois, United States, North America
Founded on
January 1, 1999
Closed on
July 6, 2016
Exited on
November 9, 2007
Went public on
November 9, 2007
Delisted on
June 30, 2016
Stock symbol
NSPH
Non-profit?
No
Acquired?
No
Employees count
51-100
Investors
Absolutely Noaccess, Blurry Noaccess, Uh Ohhhh, Cannot Access, Blurry Noaccess
Sign in for full access
Founders
Chad A. Mirkin, Robert Lewis Letsinger